Format

Send to

Choose Destination
Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1441-9. doi: 10.2215/CJN.01000116. Epub 2016 Jun 8.

Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.

Author information

1
Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan;
2
Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan; nozu@med.kobe-u.ac.jp.
3
Department of Nephrology, Toranomon Hospital, Tokyo, Japan;
4
Department of Pediatrics, The University of Tokyo, Tokyo, Japan; and.
5
Department of Pediatrics, Wakayama Medical University, Wakayama, Japan.

Abstract

BACKGROUND AND OBJECTIVES:

Alport syndrome comprises a group of inherited heterogeneous disorders involving CKD, hearing loss, and ocular abnormalities. Autosomal dominant Alport syndrome caused by heterozygous mutations in collagen 4A3 and/or collagen 4A4 accounts for <5% of patients. However, the clinical, genetic, and pathologic backgrounds of patients with autosomal dominant Alport syndrome remain unclear.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS:

We conducted a retrospective analysis of 25 patients with genetically proven autosomal dominant Alport syndrome and their family members (a total of 72 patients) from 16 unrelated families. Patients with suspected Alport syndrome after pathologic examination who were referred from anywhere in Japan for genetic analysis from 2006 to 2015 were included in this study. Clinical, laboratory, and pathologic data were collected from medical records at the point of registration for genetic diagnosis. Genetic analysis was performed by targeted resequencing of 27 podocyte-related genes, including Alport-related collagen genes, to make a diagnosis of autosomal dominant Alport syndrome and identify modifier genes or double mutations. Clinical data were obtained from medical records.

RESULTS:

The median renal survival time was 70 years, and the median age at first detection of proteinuria was 17 years old. There was one patient with hearing loss and one patient with ocular lesion. Among 16 patients who underwent kidney biopsy, three showed FSGS, and seven showed thinning without lamellation of the glomerular basement membrane. Five of 13 detected mutations were reported to be causative mutations for autosomal recessive Alport syndrome in previous studies. Two families possessed double mutations in both collagen 4A3 and collagen 4A4, but no modifier genes were detected among the other podocyte-related genes.

CONCLUSIONS:

The renal phenotype of autosomal dominant Alport syndrome was much milder than that of autosomal recessive Alport syndrome or X-linked Alport syndrome in men. It may, thus, be difficult to make an accurate diagnosis of autosomal dominant Alport syndrome on the basis of clinical or pathologic findings. No modifier genes were identified among the known podocyte-related genes.

KEYWORDS:

Alport syndrome; Autosomal dominant; COL4A3; COL4A4; Glomerular Basement Membrane; Hearing Loss; Humans; Japan; Phenotype; Renal Insufficiency, Chronic; kidney; proteinuria

PMID:
27281700
PMCID:
PMC4974872
DOI:
10.2215/CJN.01000116
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center